FHCRX — Select Health Care Portfolio
Data updated: 2026-07-24
FHCRX — Select Health Care Portfolio data: holdings, portfolio allocation, expenses, performance, cashflows, risk and SEC filings. United States Health Care Equity · $5.78B AUM · 0.55% expense ratio. From SEC regulatory filings.
FHCRX Fund Overview
FHCRX — Select Health Care Portfolio is a US mutual fund managed by Fidelity Select Portfolios, categorised as United States Health Care Equity. ABC INVEST provides holdings, performance, costs, cashflows, risk data, prospectus documents and SEC filings, sourced from SEC filings.
- Type: US mutual fund
- Manager: Fidelity Select Portfolios
- Category: United States Health Care Equity
- Assets under management: $5.78B
- Ticker: FHCRX
- SEC CIK: 0000320351
- SEC series ID: S000007466
- Share class ID: C000272242
FHCRX Holdings
Top 10 holdings of Select Health Care Portfolio by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets |
|---|---|
| ELI LILLY and CO | 8.03% |
| Danaher Corp. | 6.89% |
| JOHNSON and JOHNSON | 4.91% |
| Thermo Fisher Scientific, Inc. | 4.33% |
| Unitedhealth Group, Inc. | 3.49% |
| Alnylam Pharmaceuticals, Inc. | 2.40% |
| Gilead Sciences, Inc. | 2.21% |
| Boston Scientific Corp. | 2.17% |
| Ascendis Pharma A/s | 2.17% |
| Fidelity Revere Street Trust | 2.17% |
FHCRX Portfolio Allocation
Asset-class allocation of Select Health Care Portfolio by percentage of net assets, from the latest SEC N-PORT filing.
| Asset class | Allocation |
|---|---|
| Equity | 99.7% |
| Cash & Equivalents | 2.4% |
| Fixed Income | 0.1% |
FHCRX Performance
Total returns for FHCRX (as of 2026-08-01), from SEC filings.
| Period | Total return |
|---|---|
| YTD | -1.9% |
| 1 year | 19.5% |
| 3 years (annualised) | 6.8% |
| 5 years (annualised) | 2.5% |
FHCRX Risk Information
Risk metrics for FHCRX, derived from monthly returns in SEC filings.
- 1-year volatility (annualised): 13.5%
FHCRX Costs and Fees
FHCRX costs about $55 per $10,000 invested per year in fund expenses.
- Net expense ratio: 0.55%
- Gross expense ratio: 0.55%
- Portfolio turnover: 69%
- Brokerage commissions: 3.32 bps of average net assets (SEC N-CEN)
FHCRX Cashflows
Over the 12 months to 2026-02, Select Health Care Portfolio had net outflows of $595.00M, from monthly SEC N-PORT filings.
| Month | Net flow |
|---|---|
| 2026-02 | −$64.74M |
| 2026-01 | −$87.83M |
| 2025-12 | $321.26M |
| 2025-11 | −$57.78M |
| 2025-10 | −$87.21M |
| 2025-09 | −$99.40M |
FHCRX Debt Constituents
Largest debt holdings of Select Health Care Portfolio by percentage of net assets, from the latest SEC N-PORT filing.
| Debt holding | % of net assets |
|---|---|
| Galvanize Therapeutics | 0.14% |
FHCRX Prospectus and SEC Filings
Official Select Health Care Portfolio filings on SEC EDGAR — prospectus, portfolio holdings and annual reports.
Related Funds
Other United States Health Care Equity funds tracked on ABC INVEST:
Data Sources
ABC INVEST compiles this page from public filings made to the U.S. Securities and Exchange Commission (SEC) through EDGAR: portfolio holdings and monthly cashflows from Form N-PORT, expenses and returns from fund prospectuses (Form 485BPOS) and the SEC DERA Risk/Return Summary data sets, annual data from Form N-CEN, and shareholder reports from Form N-CSR.